PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune liver disease https://www.medrxiv.org/content/10.1101/2023.07.17.23292183
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune liver disease https://www.medrxiv.org/content/10.1101/2023.07.17.23292183